Dietlinde Janson

Standardized monitoring of cytomegalovirus-specific immunity can improve risk stratification of recurrent cytomegalovirus reactivation after hematopoietic stem cell transplantation

Eva Wagner-Drouet, Daniel Teschner, Christine Wolschke et al. · Haematologica · 2019 · 44 citations · Full text

Cell Therapy, Cytomegalovirus-specific Cellular Immunity, Immunodeficiencies +19

Ruxolitinib plus extracorporeal photopheresis (ECP) for steroid refractory acute graft-versus-host disease of lower GI-tract after allogeneic stem cell transplantation leads to increased regulatory T cell level

Franziska Modemann, Francis Ayuk, Christine Wolschke et al. · Bone Marrow Transplantation · 2020 · 35 citations · Full text

Translational Medicine, Chronic Gvhd, Transplantation +15

Enhanced Immune Reconstitution of γδ T Cells after Allogeneic Stem Cell Transplantation Overcomes the Negative Impact of Pretransplantation Minimal Residual Disease-Positive Status in Patients with Acute Myelogenous Leukemia

Evgeny Klyuchnikov, Anita Badbaran, Radwan Massoud et al. · Transplantation and Cellular Therapy · 2021 · 23 citations

Molecular monitoring of T-cell kinetics and migration in severe neurotoxicity after real-world CD19-specific chimeric antigen receptor T cell therapy

Susanna Carolina Berger, Boris Fehse, Nuray Akyüz et al. · Haematologica · 2022 · 22 citations · Full text

Car T-cell Enrichment, Cell Therapy, T-regulatory Cell +22

Risk factors for outcome after allogeneic stem cell transplantation in patients with advanced phase CML

Christian Niederwieser, L. S. Zubarovskaya, Tatjana Zabelina et al. · Bone Marrow Transplantation · 2021 · 21 citations · Full text